ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buyse, B
Right arrow Articles by Demedts, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buyse, B
Right arrow Articles by Demedts, M
Eur Respir J 1997; 10: 1401-1404
Copyright © ERS Journals Ltd 1997

Case Studies

Relief of sleep apnoea after treatment of acromegaly: report of three cases and review of the literature

B Buyse, E Michiels, R Bouillon, H Bobbaers, and M Demedts

Sleep apnoea syndrome (SAS) is common in acromegalic patients. Occasionally, the relief of apnoeas after treatment of the acromegaly has been documented. We report the cases of three patients with acromegaly and severe obstructive sleep apnoea, who demonstrated a manifest improvement (respiratory disturbance index (RDI) <20) after treatment with octreotide, indicating that this drug may be effective in this disturbance. In one case, SAS disappeared although the growth hormone level was not fully normalized. This raises the intriguing hypothesis that octreotide has an effect on respiratory control or on the upper airway, that is not directly related to its action on production of growth hormone.


This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
M. V. Davi', L. D. Carbonare, A. Giustina, M. Ferrari, A. Frigo, V. Lo Cascio, and G. Francia
Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease
Eur. J. Endocrinol., November 1, 2008; 159(5): 533 - 540.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
F. R B van Haute, G. F Taboada, L. L Correa, G. A B Lima, R. Fontes, A. P. Riello, M. Dominici, and M. R Gadelha
Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging.
Eur. J. Endocrinol., April 1, 2008; 158(4): 459 - 465.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. P Matta, E. Couture, L. Cazals, D. Vezzosi, A. Bennet, and P. Caron
Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance
Eur. J. Endocrinol., March 1, 2008; 158(3): 305 - 310.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
L. Sze, C. Schmid, K. E Bloch, R. Bernays, and M. Brandle
Effect of transsphenoidal surgery on sleep apnoea in acromegaly
Eur. J. Endocrinol., March 1, 2007; 156(3): 321 - 329.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. A. M. Festen, A. W. de Weerd, R. A. S. van den Bossche, K. Joosten, H. Hoeve, and A. C. S. Hokken-Koelega
Sleep-Related Breathing Disorders in Prepubertal Children with Prader-Willi Syndrome and Effects of Growth Hormone Treatment
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4911 - 4915.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the European Respiratory Society.